HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Cancer Cell (Impact Factor: 23.89). 10/2007; 12(3):230-8. DOI: 10.1016/j.ccr.2007.08.004
Source: PubMed

ABSTRACT The antitumorigenic activity of antioxidants has been presumed to arise from their ability to squelch DNA damage and genomic instability mediated by reactive oxygen species (ROS). Here, we report that antioxidants inhibited three tumorigenic models in vivo. Inhibition of a MYC-dependent human B lymphoma model was unassociated with genomic instability but was linked to diminished hypoxia-inducible factor (HIF)-1 levels in a prolyl hydroxylase 2 and von Hippel-Lindau protein-dependent manner. Ectopic expression of an oxygen-independent, stabilized HIF-1 mutant rescued lymphoma xenografts from inhibition by two antioxidants: N-acetylcysteine and vitamin C. These findings challenge the paradigm that antioxidants diminish tumorigenesis primarily through decreasing DNA damage and mutations and provide significant support for a key antitumorigenic effect of diminishing HIF levels.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Reactive oxygen species (ROS) can initiate cancer, but oxidant generation in tumors leaves them vulnerable to further stresses. In this issue of Cancer Cell, Harris and colleagues show that augmenting oxidant stress in normal cells limits tumor initiation and progression. Hence, strategic targeting of antioxidant systems may undermine survival of new tumor cells. Copyright © 2015 Elsevier Inc. All rights reserved.
    Cancer Cell 02/2015; 27(2):156-7. DOI:10.1016/j.ccell.2015.01.007 · 23.89 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bladder cancer is a common human cancer with very high recurrence rate. Apple polyphenols (APs) possess anti-cancer, anti-oxidation, and anti-inflammation properties. The effect of APs in human bladder transitional cell carcinoma (TCC, TSGH-8301 cells) was examined. The results showed AP reduces cell viability and causes cell cycle arrest at G2/M phase involving the decrease of cyclin B1 and cdc2. AP also increases the subG1 ratio in cell cycle, decreases the mitochondrial membrane potential, and alters the expression of apoptosis related proteins, apoptosis inducing factor (AIF), Bcl2, and caspase 3. It can cause the phenomenon of mitotic catastrophe with multi-nucleation and reduction of microtubule molecule. AP markedly reduces tumor size in TSGH-8301 cells-xenografted examination and induced the pattern of cell death as well as in cell system. In conclusion, AP possesses the potential to mediate cell cycle arrest, apoptosis, and mitotic catastrophe in TCC.
    Journal of Functional Foods 04/2015; 14. DOI:10.1016/j.jff.2015.02.002 · 4.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Myeloid-derived suppressor cells (MDSCs) contribute to tumor-mediated immune escape and negatively correlate with overall survival of cancer patients. Nowadays, a variety of methods to target MDSCs are being investigated. Based on the intervention stage of MDSCs, namely development, expansion and activation, function and turnover, these methods can be divided into: (I) prevention or differentiation to mature cells, (II) blockade of MDSC expansion and activation, (III) inhibition of MDSC suppressive activity or (IV) depletion of intratumoral MDSCs. This review describes effective mono- or multimodal-therapies that target MDSCs for the benefit of cancer treatment.
    OncoImmunology 01/2015; 4(1):e954829. DOI:10.4161/21624011.2014.954829 · 6.28 Impact Factor